These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1597263)

  • 1. Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
    Elmazar MM; Thiel R; Nau H
    Fundam Appl Toxicol; 1992 Apr; 18(3):389-94. PubMed ID: 1597263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate increases valproic acid-induced developmental toxicity, in particular neural tube defects in mice.
    Elmazar MM; Nau H
    Teratog Carcinog Mutagen; 1992; 12(5):203-10. PubMed ID: 1363493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid-induced spina bifida: a mouse model.
    Ehlers K; Stürje H; Merker HJ; Nau H
    Teratology; 1992 Feb; 45(2):145-54. PubMed ID: 1377411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exencephaly and axial skeletal malformations induced by maternal administration of sodium valproate in the MF1 mouse.
    Padmanabhan R; Hameed MS
    J Craniofac Genet Dev Biol; 1994; 14(3):192-205. PubMed ID: 7852547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of valproic acid on fetal and maternal organs in the mouse: a morphological study.
    Emmanouil-Nikoloussi EN; Foroglou NG; Kerameos-Foroglou CH; Thliveris JA
    Morphologie; 2004 Apr; 88(280):41-5. PubMed ID: 15208813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of sodium valproate-induced neural tube defects in mouse fetuses by maternal folic acid supplementation during gestation.
    Padmanabhan R; Shafiullah MM
    Congenit Anom (Kyoto); 2003 Mar; 43(1):29-40. PubMed ID: 12692401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of maternal exposure to homocystine on sodium valproate-induced neural tube defects in the mouse embryos.
    Padmanabhan R; Shafiullah M; Benedict S; Nagelkerke N
    Eur J Nutr; 2006 Sep; 45(6):311-9. PubMed ID: 16699836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diurnal variation of folate concentrations in mouse embryo and plasma: the protective effect of folinic acid on valproic-acid-induced teratogenicity is time dependent.
    Wegner C; Nau H
    Reprod Toxicol; 1991; 5(6):465-71. PubMed ID: 1810574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol potentiates valproic acid-induced neural tube defects (NTDs) in mice due to toxicokinetic interactions.
    Elmazar MM; Nau H
    Reprod Toxicol; 1995; 9(5):427-33. PubMed ID: 8563186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
    Hansen DK; Grafton TF; Dial SL; Gehring TA; Siitonen PH
    Teratology; 1995 Nov; 52(5):277-85. PubMed ID: 8838251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim potentiates valproic acid-induced neural tube defects (NTDs) in mice.
    Elmazar MM; Nau H
    Reprod Toxicol; 1993; 7(3):249-54. PubMed ID: 8318756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pantothenic acid decreases valproic acid-induced neural tube defects in mice (I).
    Sato M; Shirota M; Nagao T
    Teratology; 1995 Sep; 52(3):143-8. PubMed ID: 8638254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valnoctamide, valpromide and valnoctic acid are much less teratogenic in mice than valproic acid.
    Radatz M; Ehlers K; Yagen B; Bialer M; Nau H
    Epilepsy Res; 1998 Mar; 30(1):41-8. PubMed ID: 9551843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of the teratogenic effects induced by coadministration of retinoic acid or phytanic acid/phytol with synthetic retinoid receptor ligands.
    Elmazar MM; Nau H
    Arch Toxicol; 2004 Nov; 78(11):660-8. PubMed ID: 15558240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid-induced neural tube defects: reduction by folinic acid in the mouse.
    Trotz M; Wegner C; Nau H
    Life Sci; 1987 Jul; 41(1):103-10. PubMed ID: 3110521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.
    Nau H; Hauck RS; Ehlers K
    Pharmacol Toxicol; 1991 Nov; 69(5):310-21. PubMed ID: 1803343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The valproic acid metabolite E-2-n-propyl-2-pentenoic acid does not induce spina bifida in the mouse.
    Ehlers K; Stürje H; Merker HJ; Nau H
    Dev Pharmacol Ther; 1992; 19(4):196-204. PubMed ID: 1343622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spina bifida aperta induced by valproic acid and by all-trans-retinoic acid in the mouse: distinct differences in morphology and periods of sensitivity.
    Ehlers K; Stürje H; Merker HJ; Nau H
    Teratology; 1992 Aug; 46(2):117-30. PubMed ID: 1440416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice.
    Downing C; Biers J; Larson C; Kimball A; Wright H; Ishii T; Gilliam D; Johnson T
    Toxicol Sci; 2010 Aug; 116(2):632-9. PubMed ID: 20457659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of attenuation of valproic acid-induced effects by folinic acid in rat embryos in vitro.
    Hansen DK; Grafton TF
    Teratology; 1991 Jun; 43(6):575-82. PubMed ID: 1882348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.